🇺🇸 FDA

Company profile · Sponsor

Quince

Quince Therapeutics

QNCX · NYSE biotech SOUTH SAN FRANCISCO, CA, USA
Pipeline
10
Drugs
0
Patents
1

Quick answer

Quince (QNCX) is a biotech company. headquartered in SOUTH SAN FRANCISCO, CA, USA. listed on NYSE. NovaPharmaNews links 10 pipeline programs, 0 drugs, and 1 patent to this profile..

Company facts

Ticker QNCX
Exchange NYSE
Company type biotech
Headquarters SOUTH SAN FRANCISCO, CA, USA
SEC CIK 0001662774

Pipeline (10)

Search pipeline →

  1. Dexamethasone

    Quince

    Crohn's Disease

    phase 3 small molecule terminated

    1 trial

  2. Dexamethasone sodium phosphate

    Quince

    Ataxia Telangiectasia

    phase 3 small molecule completed

    2 trials

  3. Dexamethasone sodium phosphate for encapsulation into autoerythrocytes

    Quince

    Ataxia Telangiectasia (A-T)

    phase 3 small molecule active

    1 trial

  4. EryDex Low dose DSP

    Quince

    Nervous System Disease

    phase 3 small molecule completed

    1 trial

  5. EryDex System

    Quince

    Ataxia Telangiectasia

    phase 3 other terminated

    1 trial

  6. Sodium chloride 0.372% solution, Dexamethasone sodium phosphate for encapsulation into autoerythrocytes

    Quince

    Ataxia Telangiectasia

    phase 3 small molecule active

    1 trial

  7. Dex 21-P

    Quince

    Ulcerative Colitis

    phase 2 small molecule completed

    1 trial

  8. Dexamethasone

    Quince

    Nervous System Disorder

    phase 2 small molecule completed

    1 trial

  9. DSP loaded RBC using EryDex System

    Quince

    Healthy

    phase 1 small molecule completed

    1 trial

  10. EryDex (dexamethasone sodium phosphate encapsulated erythrocytes)

    Quince

    Healthy

    phase 1 small molecule completed

    1 trial

Patents (1)

Search patents →

  1. US 12311059

    Process for the preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes

    Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Quince?

Quince (QNCX) is a biotech company. headquartered in SOUTH SAN FRANCISCO, CA, USA. listed on NYSE. NovaPharmaNews links 10 pipeline programs, 0 drugs, and 1 patent to this profile..

What pipeline programs does Quince sponsor?

We track 10 ClinicalTrials.gov-linked programs for Quince, including Dexamethasone and 9 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Quince company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.